FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:SMCHD1-NDC80

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: SMCHD1-NDC80
FusionPDB ID: 84030
FusionGDB2.0 ID: 84030
HgeneTgene
Gene symbol

SMCHD1

NDC80

Gene ID

23347

10403

Gene namestructural maintenance of chromosomes flexible hinge domain containing 1NDC80 kinetochore complex component
SynonymsBAMS|FSHD2HEC|HEC1|HsHec1|KNTC2|TID3|hsNDC80
Cytomap

18p11.32

18p11.32

Type of geneprotein-codingprotein-coding
Descriptionstructural maintenance of chromosomes flexible hinge domain-containing protein 1SMC hinge domain-containing protein 1kinetochore protein NDC80 homologNDC80 homolog, kinetochore complex componentNDC80 kinetochore complex component homologhighly expressed in cancer proteinhighly expressed in cancer, rich in leucine heptad repeatskinetochore associated 2kinetochore p
Modification date2020031320200327
UniProtAcc.

O14777

Main function of 5'-partner protein: FUNCTION: Acts as a component of the essential kinetochore-associated NDC80 complex, which is required for chromosome segregation and spindle checkpoint activity (PubMed:9315664, PubMed:12351790, PubMed:14654001, PubMed:14699129, PubMed:15062103, PubMed:15235793, PubMed:15239953, PubMed:15548592, PubMed:16732327). Required for kinetochore integrity and the organization of stable microtubule binding sites in the outer plate of the kinetochore (PubMed:15548592). The NDC80 complex synergistically enhances the affinity of the SKA1 complex for microtubules and may allow the NDC80 complex to track depolymerizing microtubules (PubMed:23085020). Plays a role in chromosome congression and is essential for the end-on attachment of the kinetochores to spindle microtubules (PubMed:25743205, PubMed:23891108). {ECO:0000269|PubMed:12351790, ECO:0000269|PubMed:14654001, ECO:0000269|PubMed:14699129, ECO:0000269|PubMed:15062103, ECO:0000269|PubMed:15235793, ECO:0000269|PubMed:15239953, ECO:0000269|PubMed:15548592, ECO:0000269|PubMed:16732327, ECO:0000269|PubMed:23085020, ECO:0000269|PubMed:23891108, ECO:0000269|PubMed:25743205, ECO:0000269|PubMed:9315664}.
Ensembl transtripts involved in fusion geneENST idsENST00000261598, ENST00000320876, 
ENST00000609587, 
ENST00000261597, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score6 X 9 X 6=3243 X 8 X 5=120
# samples 118
** MAII scorelog2(11/324*10)=-1.55849028935997
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(8/120*10)=-0.584962500721156
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: SMCHD1 [Title/Abstract] AND NDC80 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: SMCHD1 [Title/Abstract] AND NDC80 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)SMCHD1(2656260)-NDC80(2601395), # samples:3
Anticipated loss of major functional domain due to fusion event.SMCHD1-NDC80 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
SMCHD1-NDC80 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
SMCHD1-NDC80 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
SMCHD1-NDC80 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneSMCHD1

GO:0009048

dosage compensation by inactivation of X chromosome

23542155



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr18:2656260/chr18:2601395)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across SMCHD1 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across NDC80 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000320876SMCHD1chr182688745+ENST00000261597NDC80chr182585111+262212113142560748
ENST00000261598SMCHD1chr182688745+ENST00000261597NDC80chr182585111+247310621652411748
ENST00000320876SMCHD1chr182688745+ENST00000261597NDC80chr182585112+262212113142560748
ENST00000261598SMCHD1chr182688745+ENST00000261597NDC80chr182585112+247310621652411748
ENST00000320876SMCHD1chr182732490-ENST00000261597NDC80chr182599018+4383361431443211335
ENST00000261598SMCHD1chr182732490-ENST00000261597NDC80chr182599018+4234346516541721335

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000320876ENST00000261597SMCHD1chr182688745+NDC80chr182585111+0.0005154430.99948454
ENST00000261598ENST00000261597SMCHD1chr182688745+NDC80chr182585111+0.0005760810.999424
ENST00000320876ENST00000261597SMCHD1chr182688745+NDC80chr182585112+0.0005154430.99948454
ENST00000261598ENST00000261597SMCHD1chr182688745+NDC80chr182585112+0.0005760810.999424
ENST00000320876ENST00000261597SMCHD1chr182732490-NDC80chr182599018+0.0001231480.99987686
ENST00000261598ENST00000261597SMCHD1chr182732490-NDC80chr182599018+0.0001138590.99988616

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for SMCHD1-NDC80

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
SMCHD1chr182688745NDC80chr1825851111062299KEAIYSGYIRNRKIHTAMKESSPLFD
SMCHD1chr182688745NDC80chr1825851111211299KEAIYSGYIRNRKIHTAMKESSPLFD
SMCHD1chr182688745NDC80chr1825851121062299KEAIYSGYIRNRKIHTAMKESSPLFD
SMCHD1chr182688745NDC80chr1825851121211299KEAIYSGYIRNRKIHTAMKESSPLFD
SMCHD1chr182732490NDC80chr18259901834651100EINITSALAEKIKIETQLAEYHKLAR
SMCHD1chr182732490NDC80chr18259901836141100EINITSALAEKIKIETQLAEYHKLAR

Top

Potential FusionNeoAntigen Information of SMCHD1-NDC80 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
SMCHD1-NDC80_2688745_2585111.msa
SMCHD1-NDC80_2732490_2599018.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
SMCHD1-NDC80chr182688745chr1825851111062HLA-B14:01NRKIHTAM0.99870.53991018
SMCHD1-NDC80chr182688745chr1825851111062HLA-B14:02NRKIHTAM0.99870.53991018
SMCHD1-NDC80chr182688745chr1825851111062HLA-B39:06IRNRKIHTA0.97170.7671817
SMCHD1-NDC80chr182688745chr1825851111062HLA-B52:01SGYIRNRKI0.0870.5179514
SMCHD1-NDC80chr182688745chr1825851111062HLA-B39:12NRKIHTAM0.99530.70441018
SMCHD1-NDC80chr182688745chr1825851111062HLA-B14:03NRKIHTAM0.9680.55011018
SMCHD1-NDC80chr182688745chr1825851111062HLA-B27:14IRNRKIHTA0.99850.6261817
SMCHD1-NDC80chr182688745chr1825851111062HLA-B73:01IRNRKIHTA0.99120.5567817
SMCHD1-NDC80chr182688745chr1825851111062HLA-B39:12IRNRKIHTA0.84230.7918817
SMCHD1-NDC80chr182688745chr1825851111062HLA-B14:03IRNRKIHTA0.41530.5561817
SMCHD1-NDC80chr182688745chr1825851111062HLA-C12:16IRNRKIHTA0.00120.9303817
SMCHD1-NDC80chr182688745chr1825851111062HLA-B15:68RNRKIHTAM0.96660.5398918
SMCHD1-NDC80chr182688745chr1825851111062HLA-C06:08IRNRKIHTA0.89190.9858817
SMCHD1-NDC80chr182688745chr1825851111062HLA-C07:22IRNRKIHTA0.53420.5688817
SMCHD1-NDC80chr182688745chr1825851111062HLA-C06:02IRNRKIHTA0.0770.9932817
SMCHD1-NDC80chr182688745chr1825851111062HLA-C06:17IRNRKIHTA0.0770.9932817
SMCHD1-NDC80chr182688745chr1825851111062HLA-A30:01RNRKIHTAMK0.9950.7595919
SMCHD1-NDC80chr182732490chr1825990183465HLA-B39:01EKIKIETQL0.99470.9397918
SMCHD1-NDC80chr182732490chr1825990183465HLA-B38:02EKIKIETQL0.9890.9658918
SMCHD1-NDC80chr182732490chr1825990183465HLA-B14:02EKIKIETQL0.98780.8902918
SMCHD1-NDC80chr182732490chr1825990183465HLA-B14:01EKIKIETQL0.98780.8902918
SMCHD1-NDC80chr182732490chr1825990183465HLA-B38:01EKIKIETQL0.98730.957918
SMCHD1-NDC80chr182732490chr1825990183465HLA-B52:01SALAEKIKI0.98350.8649514
SMCHD1-NDC80chr182732490chr1825990183465HLA-A30:08KIKIETQLA0.98060.85431019
SMCHD1-NDC80chr182732490chr1825990183465HLA-B15:25KIETQLAEY0.97310.88381221
SMCHD1-NDC80chr182732490chr1825990183465HLA-B15:10EKIKIETQL0.88510.5767918
SMCHD1-NDC80chr182732490chr1825990183465HLA-B15:37EKIKIETQL0.71930.6804918
SMCHD1-NDC80chr182732490chr1825990183465HLA-A02:13ALAEKIKIET0.97860.8295616
SMCHD1-NDC80chr182732490chr1825990183465HLA-A02:27ALAEKIKIET0.97110.7376616
SMCHD1-NDC80chr182732490chr1825990183465HLA-B47:01AEKIKIETQL0.9610.5664818
SMCHD1-NDC80chr182732490chr1825990183465HLA-B44:03AEKIKIETQL0.93620.9596818
SMCHD1-NDC80chr182732490chr1825990183465HLA-B15:03IKIETQLAEY0.91840.68771121
SMCHD1-NDC80chr182732490chr1825990183465HLA-B15:18IKIETQLAEY0.8990.60591121
SMCHD1-NDC80chr182732490chr1825990183465HLA-B39:13AEKIKIETQL0.83990.9676818
SMCHD1-NDC80chr182732490chr1825990183465HLA-B45:01AEKIKIETQLA0.99770.8713819
SMCHD1-NDC80chr182732490chr1825990183465HLA-B39:09EKIKIETQL0.99510.7025918
SMCHD1-NDC80chr182732490chr1825990183465HLA-B39:12EKIKIETQL0.99230.947918
SMCHD1-NDC80chr182732490chr1825990183465HLA-B39:05EKIKIETQL0.98140.9203918
SMCHD1-NDC80chr182732490chr1825990183465HLA-B15:05KIETQLAEY0.88710.83831221
SMCHD1-NDC80chr182732490chr1825990183465HLA-B14:03EKIKIETQL0.45870.8877918
SMCHD1-NDC80chr182732490chr1825990183465HLA-B15:07KIKIETQLAEY0.99990.70521021
SMCHD1-NDC80chr182732490chr1825990183465HLA-C15:05SALAEKIKI0.99930.8488514
SMCHD1-NDC80chr182732490chr1825990183465HLA-C15:02SALAEKIKI0.99920.7998514
SMCHD1-NDC80chr182732490chr1825990183465HLA-B39:02EKIKIETQL0.99560.9541918
SMCHD1-NDC80chr182732490chr1825990183465HLA-B39:31EKIKIETQL0.99490.9404918
SMCHD1-NDC80chr182732490chr1825990183465HLA-B38:05EKIKIETQL0.98730.957918
SMCHD1-NDC80chr182732490chr1825990183465HLA-A30:01KIKIETQLA0.98150.94841019
SMCHD1-NDC80chr182732490chr1825990183465HLA-B15:39KIETQLAEY0.97330.80421221
SMCHD1-NDC80chr182732490chr1825990183465HLA-A02:03ALAEKIKIET0.99280.7817616
SMCHD1-NDC80chr182732490chr1825990183465HLA-B40:04AEKIKIETQL0.99110.653818
SMCHD1-NDC80chr182732490chr1825990183465HLA-B15:53IKIETQLAEY0.9530.85261121
SMCHD1-NDC80chr182732490chr1825990183465HLA-B44:26AEKIKIETQL0.93620.9596818
SMCHD1-NDC80chr182732490chr1825990183465HLA-B44:13AEKIKIETQL0.93620.9596818
SMCHD1-NDC80chr182732490chr1825990183465HLA-B44:07AEKIKIETQL0.93620.9596818
SMCHD1-NDC80chr182732490chr1825990183465HLA-B15:54IKIETQLAEY0.92150.82231121
SMCHD1-NDC80chr182732490chr1825990183465HLA-B48:02IKIETQLAEY0.83920.86461121
SMCHD1-NDC80chr182732490chr1825990183465HLA-B15:68IKIETQLAEY0.83830.60071121
SMCHD1-NDC80chr182732490chr1825990183465HLA-B41:03AEKIKIETQL0.82950.5625818
SMCHD1-NDC80chr182732490chr1825990183465HLA-B15:35KIKIETQLAEY0.99990.90681021

Top

Potential FusionNeoAntigen Information of SMCHD1-NDC80 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
SMCHD1-NDC80_2688745_2585111.msa
SMCHD1-NDC80_2732490_2599018.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
SMCHD1-NDC80chr182688745chr1825851111062DRB1-1150RNRKIHTAMKESSPL924
SMCHD1-NDC80chr182688745chr1825851111062DRB1-1156RNRKIHTAMKESSPL924
SMCHD1-NDC80chr182688745chr1825851111062DRB1-1183RNRKIHTAMKESSPL924
SMCHD1-NDC80chr182688745chr1825851111062DRB1-1183NRKIHTAMKESSPLF1025
SMCHD1-NDC80chr182688745chr1825851111062DRB1-1188RNRKIHTAMKESSPL924
SMCHD1-NDC80chr182688745chr1825851111062DRB1-1336YSGYIRNRKIHTAMK419
SMCHD1-NDC80chr182688745chr1825851111062DRB1-1367YSGYIRNRKIHTAMK419
SMCHD1-NDC80chr182688745chr1825851111062DRB1-1367SGYIRNRKIHTAMKE520
SMCHD1-NDC80chr182688745chr1825851111062DRB1-1367IYSGYIRNRKIHTAM318
SMCHD1-NDC80chr182688745chr1825851111062DRB1-1385YSGYIRNRKIHTAMK419
SMCHD1-NDC80chr182688745chr1825851111062DRB1-1396YSGYIRNRKIHTAMK419
SMCHD1-NDC80chr182688745chr1825851111062DRB1-1424YSGYIRNRKIHTAMK419
SMCHD1-NDC80chr182688745chr1825851111062DRB1-1498YSGYIRNRKIHTAMK419
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0102EINITSALAEKIKIE015
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0117EINITSALAEKIKIE015
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0121EINITSALAEKIKIE015
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0123EINITSALAEKIKIE015
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0701EINITSALAEKIKIE015
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0703EINITSALAEKIKIE015
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0704EINITSALAEKIKIE015
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0705EINITSALAEKIKIE015
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0706EINITSALAEKIKIE015
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0707EINITSALAEKIKIE015
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0708EINITSALAEKIKIE015
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0709EINITSALAEKIKIE015
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0711EINITSALAEKIKIE015
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0712EINITSALAEKIKIE015
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0713EINITSALAEKIKIE015
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0714EINITSALAEKIKIE015
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0715EINITSALAEKIKIE015
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0716EINITSALAEKIKIE015
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0717EINITSALAEKIKIE015
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0719EINITSALAEKIKIE015
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0806AEKIKIETQLAEYHK823
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0810AEKIKIETQLAEYHK823
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0810LAEKIKIETQLAEYH722
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0812AEKIKIETQLAEYHK823
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0818AEKIKIETQLAEYHK823
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0822AEKIKIETQLAEYHK823
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0840AEKIKIETQLAEYHK823
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0901EINITSALAEKIKIE015
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0902EINITSALAEKIKIE015
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0903EINITSALAEKIKIE015
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0904EINITSALAEKIKIE015
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0905EINITSALAEKIKIE015
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0906EINITSALAEKIKIE015
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0907EINITSALAEKIKIE015
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0908EINITSALAEKIKIE015
SMCHD1-NDC80chr182732490chr1825990183465DRB1-0909EINITSALAEKIKIE015
SMCHD1-NDC80chr182732490chr1825990183465DRB1-1333AEKIKIETQLAEYHK823
SMCHD1-NDC80chr182732490chr1825990183465DRB1-1358AEKIKIETQLAEYHK823
SMCHD1-NDC80chr182732490chr1825990183465DRB1-1358LAEKIKIETQLAEYH722
SMCHD1-NDC80chr182732490chr1825990183465DRB1-1381AEKIKIETQLAEYHK823
SMCHD1-NDC80chr182732490chr1825990183465DRB1-1381LAEKIKIETQLAEYH722
SMCHD1-NDC80chr182732490chr1825990183465DRB1-1389AEKIKIETQLAEYHK823
SMCHD1-NDC80chr182732490chr1825990183465DRB1-1389LAEKIKIETQLAEYH722
SMCHD1-NDC80chr182732490chr1825990183465DRB1-1394AEKIKIETQLAEYHK823
SMCHD1-NDC80chr182732490chr1825990183465DRB1-1394LAEKIKIETQLAEYH722
SMCHD1-NDC80chr182732490chr1825990183465DRB1-1413AEKIKIETQLAEYHK823
SMCHD1-NDC80chr182732490chr1825990183465DRB1-1474AEKIKIETQLAEYHK823
SMCHD1-NDC80chr182732490chr1825990183465DRB1-1476AEKIKIETQLAEYHK823
SMCHD1-NDC80chr182732490chr1825990183465DRB1-1479AEKIKIETQLAEYHK823
SMCHD1-NDC80chr182732490chr1825990183465DRB5-0112EINITSALAEKIKIE015

Top

Fusion breakpoint peptide structures of SMCHD1-NDC80

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
337ALAEKIKIETQLAESMCHD1NDC80chr182732490chr1825990183465
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
3251GYIRNRKIHTAMKESMCHD1NDC80chr182688745chr1825851111062

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of SMCHD1-NDC80

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN337ALAEKIKIETQLAE-7.9962-8.1096
HLA-B14:023BVN337ALAEKIKIETQLAE-5.70842-6.74372
HLA-B52:013W39337ALAEKIKIETQLAE-6.83737-6.95077
HLA-B52:013W39337ALAEKIKIETQLAE-4.4836-5.5189
HLA-A11:014UQ2337ALAEKIKIETQLAE-10.0067-10.1201
HLA-A11:014UQ2337ALAEKIKIETQLAE-9.03915-10.0745
HLA-A24:025HGA337ALAEKIKIETQLAE-6.56204-6.67544
HLA-A24:025HGA337ALAEKIKIETQLAE-5.42271-6.45801
HLA-B44:053DX8337ALAEKIKIETQLAE-7.85648-8.89178
HLA-B44:053DX8337ALAEKIKIETQLAE-5.3978-5.5112
HLA-A02:016TDR337ALAEKIKIETQLAE-3.37154-4.40684
HLA-B14:023BVN3251GYIRNRKIHTAMKE-7.60556-7.71896
HLA-B14:023BVN3251GYIRNRKIHTAMKE-5.59127-6.62657
HLA-B52:013W393251GYIRNRKIHTAMKE-6.30364-6.41704
HLA-B52:013W393251GYIRNRKIHTAMKE-5.70459-6.73989
HLA-A24:025HGA3251GYIRNRKIHTAMKE-7.75337-7.86677
HLA-A24:025HGA3251GYIRNRKIHTAMKE-7.34214-8.37744
HLA-B27:056PYJ3251GYIRNRKIHTAMKE-9.9587-10.0721
HLA-B27:056PYJ3251GYIRNRKIHTAMKE-6.28314-7.31844
HLA-B44:053DX83251GYIRNRKIHTAMKE-5.13864-5.25204
HLA-B44:053DX83251GYIRNRKIHTAMKE-4.91755-5.95285
HLA-A02:016TDR3251GYIRNRKIHTAMKE-5.00517-5.11857

Top

Vaccine Design for the FusionNeoAntigens of SMCHD1-NDC80

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
SMCHD1-NDC80chr182688745chr1825851111018NRKIHTAMAACAGAAAGATACATACTGCCATG
SMCHD1-NDC80chr182688745chr182585111514SGYIRNRKIAGTGGATATATTAGAAACAGAAAGATA
SMCHD1-NDC80chr182688745chr182585111817IRNRKIHTAATTAGAAACAGAAAGATACATACTGCC
SMCHD1-NDC80chr182688745chr182585111918RNRKIHTAMAGAAACAGAAAGATACATACTGCCATG
SMCHD1-NDC80chr182688745chr182585111919RNRKIHTAMKAGAAACAGAAAGATACATACTGCCATGAAA
SMCHD1-NDC80chr182732490chr1825990181019KIKIETQLAAAAATTAAAATTGAAACACAATTAGCA
SMCHD1-NDC80chr182732490chr1825990181021KIKIETQLAEYAAAATTAAAATTGAAACACAATTAGCAGAGTAT
SMCHD1-NDC80chr182732490chr1825990181121IKIETQLAEYATTAAAATTGAAACACAATTAGCAGAGTAT
SMCHD1-NDC80chr182732490chr1825990181221KIETQLAEYAAAATTGAAACACAATTAGCAGAGTAT
SMCHD1-NDC80chr182732490chr182599018514SALAEKIKITCAGCTTTAGCAGAAAAAATTAAAATT
SMCHD1-NDC80chr182732490chr182599018616ALAEKIKIETGCTTTAGCAGAAAAAATTAAAATTGAAACA
SMCHD1-NDC80chr182732490chr182599018818AEKIKIETQLGCAGAAAAAATTAAAATTGAAACACAATTA
SMCHD1-NDC80chr182732490chr182599018819AEKIKIETQLAGCAGAAAAAATTAAAATTGAAACACAATTAGCA
SMCHD1-NDC80chr182732490chr182599018918EKIKIETQLGAAAAAATTAAAATTGAAACACAATTA

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
SMCHD1-NDC80chr182688745chr1825851111025NRKIHTAMKESSPLFAACAGAAAGATACATACTGCCATGAAAGAAAGCTCACCTTTATTT
SMCHD1-NDC80chr182688745chr182585111318IYSGYIRNRKIHTAMATATATAGTGGATATATTAGAAACAGAAAGATACATACTGCCATG
SMCHD1-NDC80chr182688745chr182585111419YSGYIRNRKIHTAMKTATAGTGGATATATTAGAAACAGAAAGATACATACTGCCATGAAA
SMCHD1-NDC80chr182688745chr182585111520SGYIRNRKIHTAMKEAGTGGATATATTAGAAACAGAAAGATACATACTGCCATGAAAGAA
SMCHD1-NDC80chr182688745chr182585111924RNRKIHTAMKESSPLAGAAACAGAAAGATACATACTGCCATGAAAGAAAGCTCACCTTTA
SMCHD1-NDC80chr182732490chr182599018015EINITSALAEKIKIEGAAATCAATATAACATCAGCTTTAGCAGAAAAAATTAAAATTGAA
SMCHD1-NDC80chr182732490chr182599018722LAEKIKIETQLAEYHTTAGCAGAAAAAATTAAAATTGAAACACAATTAGCAGAGTATCAC
SMCHD1-NDC80chr182732490chr182599018823AEKIKIETQLAEYHKGCAGAAAAAATTAAAATTGAAACACAATTAGCAGAGTATCACAAA

Top

Information of the samples that have these potential fusion neoantigens of SMCHD1-NDC80

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
LUADSMCHD1-NDC80chr182688745ENST00000261598chr182585111ENST00000261597TCGA-62-A46U
SARCSMCHD1-NDC80chr182732490ENST00000261598chr182599018ENST00000261597TCGA-IF-A4AJ-01A

Top

Potential target of CAR-T therapy development for SMCHD1-NDC80

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to SMCHD1-NDC80

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to SMCHD1-NDC80

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource